Endocare divests erectile dysfunction unit to Plethora
This article was originally published in Clinica
Executive Summary
Endocare has agreed to sell Timm Medical Technologies, its Eden Prairie, Minneapolis-based subsidiary that manufactures erectile dysfunction products, to UK speciality pharmaceutical company Plethora Solutions for $9.5m in a cash-and-bonds transaction.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.